Second, we compared the three PDL1 gene signatures (pancreas, breast, GIST) that we generated de novo from the 12,091 genes common to the three studies and using the same parameters of supervised analysis (moderated t-test, p < 5%, q < 25%, |FC|>1.5x). This evidence concerns the gene CD274 and gastrointestinal stromal tumor.